Williams Timothy 4
4 · Vanda Pharmaceuticals Inc. · Filed Feb 19, 2026
Research Summary
AI-generated summary of this filing
Vanda (VNDA) SVP Timothy Williams Receives 125,000-Share Award
What Happened
Timothy Williams, SVP and General Counsel of Vanda Pharmaceuticals (VNDA), was granted 125,000 restricted stock units (RSUs) on 2026-02-18. The RSUs were reported as acquired at $0.00 (no cash exchanged) and represent a time-based equity award rather than an open‑market purchase or sale.
Key Details
- Transaction date: 2026-02-18 (Form 4 filed 2026-02-19). Transaction code: A (award/grant).
- Amount: 125,000 RSUs; reported acquisition price: $0.00.
- Shares owned after transaction: Not specified in this filing.
- Vesting: The RSUs vest in four equal annual installments, with the first vesting on March 1, 2027, contingent on continued employment. Vested shares will be delivered on the First Permissible Trading Day following each vest date (see footnote).
- Filing timeliness: Filed the day after the transaction date (appears timely).
Context
RSUs are time‑based compensation that do not represent immediately tradable shares until they vest; they are common as retention and performance-aligned pay. Because no shares were sold or bought in the open market and the award vests over time, this grant is a compensation event rather than a direct bullish or bearish trading signal.
Insider Transaction Report
- Award
Common Stock
[F1]2026-02-18+125,000→ 419,884 total
Footnotes (1)
- [F1]Represents shares of common stock underlying a time-based restricted stock unit award ("RSU"). The RSU vests in four (4) equal annual installments with the first annual vest taking place on March 1, 2027, provided the Reporting Person remains continuously employed by the Issuer through each annual vesting date. Vested shares will be delivered on the First Permissible Trading Day (as defined in the RSU Agreement) that occurs on or after the day when the RSUs vest.